Skip to main content

Table 4 Distribution of all adverse events (1593) by intensity and causality

From: Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial

Grade Causality
n (%)
Total
Doubtful Unlikely Possible Probable/likely Highly probable
I 597 (37.5) 107 (6.7) 538 (33.8) 118 (7.4) 19 (1.2) 1379 (86.6)
II 86 (5.4) 49 (3.1) 62 (3.9) 10 (0.6) 1 (0.1) 208 (13.1)
IV 0 (0) 0 (0) 0 (0) 1 (0.1) 0 (0) 1 (0.1)
NA 3 (0.19) 2 (0.13) 0 (0) 0 (0) 0 (0) 5 (0.31)
Total 686 (43.1) 158 (9.9) 600 (37.7) 129 (8.1) 20 (1.3) 1593 (100)
  1. Italic values indicate the relevant safety outcomes